W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X
Home » dFlip Book » Tag: Transparency Council

Transparency Council

02 December, 2024

Opinion of the Transparency Council – pomalidomide

more...
02 December, 2024

Opinion of the Transparency Council – pomalidomide

more...
29 November, 2024

Communication of the meeting of Transparency Council No. 49/2024 on 25 November 2024

more...
29 November, 2024

Position of the Transparency Council – Trandate (labetalol)

more...
29 November, 2024

Position of the Transparency Council – XMTVI Maxamum

more...
29 November, 2024

Position of the Transparency Council – Tavneos (avacopan)

more...
29 November, 2024

Position of the Transparency Council – Libtayo (cemiplimab)

more...
29 November, 2024

Position of the Transparency Council – Libtayo (cemiplimab)

more...
29 November, 2024

Position of the Transparency Council – Talvey (talquetamab)

more...
26 November, 2024

The Transparency Council meeting 50/2024 on 2 December 2024

more...
21 November, 2024

Communication of the meeting of Transparency Council No. 48/2024 on 18 November 2024

more...
21 November, 2024

Position of the Transparency Council – Voxzogo (vosoritide)

more...
21 November, 2024

Position of the Transparency Council – Filsuvez (birch bark extract)

more...
21 November, 2024

Position of the Transparency Council – mexiletine

more...
21 November, 2024

Position of the Transparency Council – Elrexfio (elranatamab)

more...
21 November, 2024

Position of the Transparency Council – Shingrix

more...
21 November, 2024

Position of the Transparency Council – hypercholesterolemia

more...
21 November, 2024

Position of the Transparency Council – Luxturna (voretigene neparvovec)

more...
19 November, 2024

Communication of the meeting of Transparency Council No. 47/2024 on 12 November 2024

more...
18 November, 2024

The Transparency Council meeting 49/2024 on 25 November 2024

more...
15 November, 2024

Position of the Transparency Council – FruitiVits

more...
15 November, 2024

Position of the Transparency Council – Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)

more...
15 November, 2024

Position of the Transparency Council – Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)

more...
15 November, 2024

Position of the Transparency Council – Amvuttra (vutrisiran)

more...
Home page
News Publications Publikacje BIP
#webinaragendaAktualnościannouncement of the PresidentazathioprinumBimzelxCollegium AOTMiTcolorectal cancercommunicationCommunication from the Transparency CouncilCommunication on the Tariff CouncilCost Accounting StandardCouncil for Tariffs Affairscovering neonatal carecyclophosphamidumData acquisitiondental treatment servicesdiseases of the organ of visiondrug programmeEmplicitientecavirumetanerceptFycompagastroscopyglaucomahealth policy programhealth policy programmehealth policy programme on breast cancerhealth policy programme on infertility treatmentHealth Policy ProgrammesImpavidoin vitroInovelonJardianceMeeting of the Transparency CouncilmethotrexatumMilupa Basic-Pminimum wage increasesmycophenolate mofetilnewnew tariffsnewsNoticeNotice of the PresidentOntozryOnuregOpdivoOpdivo (nivolumab)opinionOpinion of the PresidentOpinion of the Transparency CouncilOspolotOzurdexperinatal carePonvoryPosition of the Transparency CouncilPress conferenceRecommendationRecommendation of the PresidentRenastepreportRezurocksirolimusSuliquaTariff CouncilTariffs CouncilTarification Plan 2025tenofovirum disoproxilumthe drug programme B.44the drug programme B.82The Meeting of the Tariffs CounciltrainingsTransparency CouncilTremfyaupdateVivitrolYervoy
Pokaż więcej ↓
Pokaż mniej ↑
Telefon
Email